Status:
RECRUITING
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Lead Sponsor:
University of Utah
Collaborating Sponsors:
Primary Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congenital Heart Disease in Children
Hypoxia
Eligibility:
FEMALE
0-52 years
Phase:
PHASE2
PHASE3
Brief Summary
Determine 1) the impact of abnormal fetal cerebrovascular physiology with neurodevelopmental delay (ND) outcomes and 2) how this relationship is modified by patient and environmental factors such as c...
Detailed Description
Aim 1: Determine the association of baseline cerebrovascular resistance and reactivity and pre-operative neurobehavior in neonates with complex congenital heart disease (CCHD). Exposures: The baseli...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05767385
Start Date
December 17 2021
End Date
December 1 2025
Last Update
June 25 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94143
2
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20010
3
Maine Medical Center
Scarborough, Maine, United States, 04074
4
Primary Children's Hospital
Salt Lake City, Utah, United States, 84113